Mira Pharmaceuticals, Common Stock Investor Sentiment

MIRA Stock   1.15  0.07  5.74%   
About 56% of MIRA Pharmaceuticals,'s investor base is looking to short. The analysis of overall sentiment of trading MIRA Pharmaceuticals, Common stock suggests that many investors are alarmed at this time. The current market sentiment, together with MIRA Pharmaceuticals,'s historical and current headlines, can help investors time the market. In addition, many technical investors use MIRA Pharmaceuticals, stock news signals to limit their universe of possible portfolio assets.
  

MIRA Pharmaceuticals, Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards MIRA Pharmaceuticals, can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
3 days ago at finance.yahoo.com         
MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a 5 Mi...
Yahoo News
3 days ago at newswire.com         
MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a 5 Mi...
news
3 days ago at seekingalpha.com         
MIRA Pharmaceuticals signs LOI to acquire SKNY Pharmaceuticals
seekingalpha News
over a week ago at forbes.com         
Xenoblade Chronicles X Definitive Edition Review Theyre Dolls, Not Skells
Usa forbes News
over a week ago at simplywall.st         
Companies Like MIRA Pharmaceuticals Are In A Position To Invest In Growth
Simply Wall St News at Macroaxis
over a week ago at benzinga.com         
EXCLUSIVE MIRA Pharmaceuticals Expands Pipeline, Enhances Value Proposition With Development Of Topi...
benzinga news
over a week ago at finance.yahoo.com         
MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic ...
Yahoo News
over a week ago at finance.yahoo.com         
MIRA Makes Another Pain Management Stride
Yahoo News
over two weeks ago at finance.yahoo.com         
HomeVision and Restb.ai Partner to Bring Advanced Computer Vision to Collateral Underwriting
Yahoo News
over two weeks ago at thelincolnianonline.com         
Short Interest in MIRA Pharmaceuticals, Inc. Expands By 20.2
news
over three weeks ago at benzinga.com         
EXCLUSIVE MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
benzinga news
over three weeks ago at newswire.com         
MIRA Pharmaceuticals Announces Approval and Initiation of Phase 1 Clinical Trial for Ketamir-2 in Ne...
news
over three weeks ago at finance.yahoo.com         
EXCLUSIVE MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
Yahoo News
over three weeks ago at finance.yahoo.com         
MIRA Announces Approval of Important Testing
Yahoo News
over three weeks ago at globenewswire.com         
MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about MIRA Pharmaceuticals, that are available to investors today. That information is available publicly through MIRA media outlets and privately through word of mouth or via MIRA internal channels. However, regardless of the origin, that massive amount of MIRA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MIRA Pharmaceuticals, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MIRA Pharmaceuticals, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MIRA Pharmaceuticals,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MIRA Pharmaceuticals, alpha.

MIRA Pharmaceuticals, Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Erez Aminov of 2000 shares of MIRA Pharmaceuticals, at 0.84 subject to Rule 16b-3
12/27/2024
2
Rising High Exclusive talk with pharmaceutical development company MIRA - TipRanks
01/16/2025
3
Acquisition by Erez Aminov of 500000 shares of MIRA Pharmaceuticals, subject to Rule 16b-3
02/20/2025
4
EXCLUSIVE MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
03/04/2025
5
Short Interest in MIRA Pharmaceuticals, Inc. Expands By 20.2
03/07/2025
6
MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain
03/13/2025
7
Xenoblade Chronicles X Definitive Edition Review Theyre Dolls, Not Skells
03/19/2025
8
MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a 5 Million Capital Infusion to Advance Weight Loss and Smoking Ce...
03/24/2025

Complementary Tools for MIRA Stock analysis

When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.